- CHEMBL493982 Ethyl [(3aR,4aR,8aR,9aS)-9(S)-[(E)-2-[5-(3-fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1(R)-methyl-3-oxonaphtho[2,3-c]furan-6(R)-yl]carbamate BDBM50261110 VORAPAXAR
- Xia, Y; Chackalamannil, S; Greenlee, WJ; Wang, Y; Hu, Z; Root, Y; Wong, J; Kong, J; Ahn, HS; Boykow, G; Hsieh, Y; Kurowski, S; Chintala, M Discovery of a vorapaxar analog with increased aqueous solubility. Bioorg Med Chem Lett 20: 6676-9 (2010)
- Fan, M; Han, M; Xia, Y; Zhang, Y; Chu, Y; Bai, G; Li, W; Li, J; Zhao, L; He, Y; Ma, X; Duan, Z Design and synthesis of potent PAR-1 antagonists based on vorapaxar. Bioorg Med Chem Lett 30: (2020)
- Chelliah, MV; Eagen, K; Guo, Z; Chackalamannil, S; Xia, Y; Tsai, H; Greenlee, WJ; Ahn, HS; Kurowski, S; Boykow, G; Hsieh, Y; Chintala, M Himbacine-derived thrombin receptor antagonists: c7-spirocyclic analogues of vorapaxar. ACS Med Chem Lett 5: 561-5 (2014)
- Chelliah, MV; Chackalamannil, S; Xia, Y; Greenlee, WJ; Ahn, HS; Kurowski, S; Boykow, G; Hsieh, Y; Chintala, M Himbacine-derived thrombin receptor antagonists: c7-aminomethyl and c9a-hydroxy analogues of vorapaxar. ACS Med Chem Lett 5: 183-7 (2014)